| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |